Staar Surgical Co SEC filings STAA
Staar Surgical Co has 1,001 filings in SEC EDGAR's recent list, going back to Aug 19, 2013. Its latest annual report, Form ARS, was filed on May 4, 2026 for the period ended Jan 2, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Oct 2, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on January 2.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 4, 2026 | — |
| DEF 14A | Proxy statement | May 4, 2026 | May 1, 2026 |
| DEFA14A | Additional proxy material | Dec 19, 2025 | — |
| DEFA14A | Additional proxy material | Dec 17, 2025 | — |
| DEFA14A | Additional proxy material | Dec 16, 2025 | — |
| DEFA14A | Additional proxy material | Dec 16, 2025 | — |
| DEFA14A | Additional proxy material | Dec 11, 2025 | — |
| DEFA14A | Additional proxy material | Dec 10, 2025 | — |
| DEFA14A | Additional proxy material | Dec 10, 2025 | — |
| DEFA14A | Additional proxy material | Dec 9, 2025 | — |
| DEFA14A | Additional proxy material | Dec 8, 2025 | — |
| DEFA14A | Additional proxy material | Nov 17, 2025 | — |
| DEFA14A | Additional proxy material | Nov 7, 2025 | — |
| DEFA14A | Additional proxy material | Oct 30, 2025 | — |
| DEFA14A | Additional proxy material | Oct 28, 2025 | — |
| DEFA14A | Additional proxy material | Oct 27, 2025 | — |
| DEFA14A | Additional proxy material | Oct 23, 2025 | — |
| DEFA14A | Additional proxy material | Oct 20, 2025 | — |
| DEFA14A | Additional proxy material | Oct 16, 2025 | — |
| DEFA14A | Additional proxy material | Oct 8, 2025 | — |
| DEFA14A | Additional proxy material | Oct 6, 2025 | — |
| DEFA14A | Additional proxy material | Oct 6, 2025 | — |
| DEFA14A | Additional proxy material | Sep 30, 2025 | — |
| DEFA14A | Additional proxy material | Sep 26, 2025 | — |
| DEFA14A | Additional proxy material | Sep 22, 2025 | — |
| DEFA14A | Additional proxy material | Sep 19, 2025 | — |
| DEFA14A | Additional proxy material | Sep 16, 2025 | — |
| DEFA14A | Additional proxy material | Sep 16, 2025 | — |
| DEFM14A | Filing | Sep 16, 2025 | — |
| DEFA14A | Additional proxy material | Sep 5, 2025 | — |
| DEFA14A | Additional proxy material | Sep 2, 2025 | — |
| PREM14A | Filing | Aug 29, 2025 | Aug 29, 2025 |
| DEFA14A | Additional proxy material | Aug 6, 2025 | — |
| DEFA14A | Additional proxy material | Aug 5, 2025 | — |
| DEFA14A | Additional proxy material | Aug 5, 2025 | — |
| DEFA14A | Additional proxy material | Aug 5, 2025 | — |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Apr 24, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 20, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | — |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 16, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2022 | Jun 16, 2022 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 24, 2021 |
| DEFA14A | Additional proxy material | Jul 14, 2020 | — |
| DEFA14A | Additional proxy material | Jun 8, 2020 | — |
| DEF 14A | Proxy statement | Jun 8, 2020 | Jul 30, 2020 |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 20, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2019 | Jun 20, 2019 |
| DEFA14A | Additional proxy material | Apr 27, 2018 | — |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 14, 2018 |
| PRE 14A | Preliminary proxy statement | Apr 13, 2018 | Apr 13, 2018 |
| DEFA14A | Additional proxy material | May 1, 2017 | — |
| DEF 14A | Proxy statement | May 1, 2017 | Jun 13, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2017 | Apr 14, 2017 |
| DEFA14A | Additional proxy material | May 2, 2016 | — |
| DEF 14A | Proxy statement | May 2, 2016 | Jun 24, 2016 |
| PRE 14A | Preliminary proxy statement | Apr 21, 2016 | Apr 21, 2016 |
| DEFA14A | Additional proxy material | Jun 4, 2015 | — |
| DEF 14A | Proxy statement | May 27, 2015 | Jul 8, 2015 |
| DEF 14A | Proxy statement | May 5, 2014 | Jun 9, 2014 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2014 | Jun 9, 2014 |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Ophthalmic Goods (SIC 3851)
- Listed as
- STAA (Nasdaq)
- Fiscal year ends
- January 2
- Incorporated in
- DE
- Headquarters
- Monrovia, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 718937
- Former names
- STAAR SURGICAL COMPANY (until Aug 17, 2004)
Other Ophthalmic Goods companies
- Alcon Inc ALC
- Cooper Companies, Inc. COO
- Bausch & Lomb Corp BLCO
- Warby Parker Inc. WRBY
- National Vision Holdings, Inc. EYE
- RxSight, Inc. RXST
- Innovative Eyewear Inc LUCY
Source: SEC EDGAR filings. This is company-reported data, not investment advice.